Skip to main content
. 2021 Jan 8;11:157. doi: 10.1038/s41598-020-79592-5

Figure 5.

Figure 5

Biodistribution and clearance of [225Ac]fCNC in immunocompetent mice at 1 and 72 h post intravenous administration showing tissue biodistribution, blood clearance and renal elimination. (A) The percent of the injected activity per gram (%IA/g) of [225Ac]fCNC in each sample and (B) the %IA/g normalized to blood activity showing the specific accumulation of fCNC in liver, spleen, and kidney along with elimination into the urine.